How do you administer a zemplar?

How do you administer a zemplar?

This medication is given by injection into a vein during dialysis, usually by a health care professional. It is given as directed by your doctor, usually 3 times a week (every other day). The dosage is based on your condition, weight, laboratory tests, and response to treatment.

When do you hold the Zemplar?

Administer ZEMPLAR three times per week, no more frequently than every other day, at any time during dialysis. Target the maintenance dose of ZEMPLAR to intact PTH levels within the desired therapeutic range and serum calcium within normal limits.

What is the generic name for Zemplar?

Paricalcitol is used to treat and prevent high levels of a certain natural substance made by the body (parathyroid hormone) in patients with long-term kidney disease.

Who manufactures zemplar?

Paricalcitol: Zemplar | AbbVie.

Why is zemplar given during dialysis?

Vitamin D is important for the absorption of calcium from the stomach and for the functioning of calcium in the body. Zemplar is used to treat or prevent overactive parathyroid gland (hyperparathyroidism) in people with chronic kidney disease who are on dialysis.

Is zemplar a vitamin D?

ZEMPLAR Capsules are an active form of vitamin D used to prevent and treat secondary hyperparathyroidism (increased parathyroid hormone levels) in adults and children 10 years of age and older with Stage 3 or Stage 4 chronic kidney disease and in Stage 5 patients on dialysis.

How does ZEMPLAR work in the body?

ZEMPLAR works by telling the parathyroid glands to stop producing too much PTH. You and your doctor may decide prescription ZEMPLAR may be an appropriate part of your treatment plan. To help manage your condition, your doctor should test your blood and adjust your ZEMPLAR medication dose based on the test results.

Why is ZEMPLAR given during dialysis?

What type of drug is zemplar?

What is ZEMPLAR? ZEMPLAR Capsules are an active form of vitamin D used to prevent and treat secondary hyperparathyroidism (increased parathyroid hormone levels) in adults and children 10 years of age and older with Stage 3 or Stage 4 chronic kidney disease and in Stage 5 patients on dialysis.

What is another name for Zemplar?

Zemplar (paricalcitol) is a synthetic (man-made) form of vitamin D. Vitamin D is important for the absorption of calcium from the stomach and for the functioning of calcium in the body.

What is Parsabiv used to treat?

This medication is used to treat increased amounts of a certain hormone (parathyroid) in people with long-term kidney disease who are on dialysis. Dialysis treatment usually causes higher than normal amounts of certain substances (such as parathyroid hormone, calcium, phosphorus) in your body.

What is Zemplar used to treat?

ZEMPLARĀ®(paricalcitol) Capsules are an active form of vitamin D used to prevent and treat secondary hyperparathyroidism (increased parathyroid hormone levels) in adults and children 10 years of age and older with Stage 3 or Stage 4 chronic kidney disease and in Stage 5 patients on dialysis. Reference: 1.

What are the ingredients in Zemplar injection?

ZEMPLAR (paricalcitol) injection is a sterile, clear, colorless, aqueous solution for intravenous use. Each mL contains paricalcitol, 2 mcg or 5 mcg and the following inactive ingredients: alcohol, 20% (v/v) and propylene glycol, 30% (v/v). Zemplar Injection – Clinical Pharmacology 12.1 Mechanism of Action

What are the indications for zonezemplar capsules?

Zemplar capsules are indicated in adults and pediatric patients 10 years of age and older for the prevention and treatment of secondary hyperparathyroidism associated with Chronic Kidney Disease (CKD) Stages 3 and 4.

How often do you take Zemplar capsules for CKD?

Zemplar capsules are indicated in adults and pediatric patients 10 years of age and older for the prevention and treatment of secondary hyperparathyroidism associated with CKD Stage 5 in patients on hemodialysis (HD) or peritoneal dialysis (PD). Administer Zemplar capsules orally once daily or three times a week [see Clinical Studies ( 14.1 )].

author

Back to Top